Mesoblast (MEOBF) Other Non-Current Liabilities (2021 - 2026)

Mesoblast has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $8.9 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 55.7% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $8.9 million (up 55.7% YoY), while the FY2026 annual figure was $8.9 million, up 55.7% from the prior year.
• Other Non-Current Liabilities came in at $8.9 million for Q2 2026 at Mesoblast, down from $14.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.2 million in Q4 2025 to a low of $992000.0 in Q4 2023.
• Average Other Non-Current Liabilities over 5 years is $6.0 million, with a median of $4.8 million recorded in 2022.
• Year-over-year, Other Non-Current Liabilities tumbled 74.78% in 2023 and surged 1254.54% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $3.9 million in 2022, then plunged by 74.78% to $992000.0 in 2023, then surged by 1254.54% to $13.4 million in 2024, then grew by 5.47% to $14.2 million in 2025, then sank by 37.12% to $8.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $8.9 million in Q2 2026, $14.2 million in Q4 2025, and $5.7 million in Q2 2025.